{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:02:19Z","timestamp":1784876539906,"version":"3.55.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cear\u00e1 Foundation for the Support of Scientific and Technological Development","award":["PS1-0186-00216.01.00\/21; 31052.000417\/2023; UNI-0210-00537.01.00\/23"],"award-info":[{"award-number":["PS1-0186-00216.01.00\/21; 31052.000417\/2023; UNI-0210-00537.01.00\/23"]}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel","doi-asserted-by":"crossref","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universidade Da Integracao Internacional Da Lusofonia Afro Brasileira"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To synthesize the available evidence on the relationship between dietary glutamate or glutamatergic metabolism and glaucomatous neurodegeneration, with emphasis on biomarkers, retinal injury mechanisms, and nutritional, antioxidant, or pharmacological strategies with neuroprotective potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was conducted as a systematic and bibliometric literature review following the PRISMA 2020 logic of identification, screening, eligibility, and inclusion. Searches were performed in Web of Science, Scopus, and PubMed for studies published in English between 2020 and 2025. The search strategy combined terms related to glaucoma or ocular neurodegeneration, the glutamatergic axis, and biomarkers, mechanisms, or interventions. After screening and full-text assessment, 39 studies were included in the systematic synthesis. Due to methodological heterogeneity, the evidence was synthesized narratively and comparatively, without meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The included studies were organized into six thematic clusters: metabolomic, transcriptomic, and diagnostic biomarkers; pharmacological and neuroprotective interventions; nutritional, antioxidant, and natural-compound neuroprotection; oxidative stress, mitochondrial dysfunction, and regulated cell death; neuroinflammation and glia-mediated retinal injury; and glutamatergic excitotoxicity and neurotransmitter imbalance. The evidence indicates that glutamate-related mechanisms in glaucoma are mainly associated with endogenous glutamatergic metabolism, excitotoxicity, impaired glutamate clearance, glutamate-glutamine homeostasis, oxidative and nitrosative stress, mitochondrial dysfunction, ferroptosis, neuroinflammation, and retinal ganglion cell vulnerability. None of the 39 included studies directly evaluated dietary glutamate or monosodium glutamate as the main exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The available evidence does not support a direct conclusion that dietary glutamate or MSG intake contributes to glaucoma onset or progression. Instead, current findings mainly support an indirect mechanistic relationship between endogenous glutamatergic dysregulation and glaucomatous neurodegeneration. Pharmacological, antioxidant, metabolic, and natural-compound strategies show neuroprotective potential, particularly in experimental models, but clinical and translational studies are still needed to clarify the role of dietary exposure, glutamate-glutamine metabolism, and targeted neuroprotective interventions in glaucoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10792-026-04179-4","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:29:49Z","timestamp":1784874589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurotoxic effects of dietary glutamate in glaucoma and potential nutritional and pharmacological therapies: a scoping review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2824-9720","authenticated-orcid":false,"given":"Larysse Maria Santiago","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Hebert","family":"da Silva Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Ara\u00fajo Oliveira","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Tayane Barroso","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio \u00c1tila Menezes","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Queiroz","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Cleiton Sousa","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alu\u00edsio Marques","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"7","key":"4179_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2174\/1570159X18666201015161919","volume":"19","author":"AY Onaolapo","year":"2021","unstructured":"Onaolapo AY, Onaolapo OJ (2021) Peripheral and central glutamate dyshomeostasis in neurodegenerative disorders. Curr Neuropharmacol 19(7):1069\u20131089. https:\/\/doi.org\/10.2174\/1570159X18666201015161919","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"4179_CR2","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/biomedicines12071518","volume":"12","author":"L Raiteri","year":"2024","unstructured":"Raiteri L (2024) Interactions involving glycine and other amino acid neurotransmitters: focus on transporter-mediated regulation of release and glycine\u2013glutamate crosstalk. Biomed 12(7):1518. https:\/\/doi.org\/10.3390\/biomedicines12071518","journal-title":"Biomed"},{"key":"4179_CR3","doi-asserted-by":"publisher","first-page":"100286","DOI":"10.1016\/j.ijgfs.2020.100286","volume":"23","author":"KN Wijayasekara","year":"2021","unstructured":"Wijayasekara KN, Wansapala J (2021) Comparison of a flavor enhancer made with locally available ingredients against commercially available Mono Sodium Glutamate. Int J Gastron Food Sci 23:100286. https:\/\/doi.org\/10.1016\/j.ijgfs.2020.100286","journal-title":"Int J Gastron Food Sci"},{"key":"4179_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.578922","author":"ID Lim\u00f3n","year":"2021","unstructured":"Lim\u00f3n ID, Angulo-Cruz I, S\u00e1nchez-Abdon L, Patricio-Mart\u00ednez A (2021) \u2018Disturbance of the Glutamate-Glutamine cycle, secondary to hepatic damage Compromises Memory Function.\u2019 Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2021.578922","journal-title":"Front Neurosci"},{"issue":"11","key":"4179_CR5","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu A-G, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM (2022) Neurotransmitters\u2014key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci 23(11):5954. https:\/\/doi.org\/10.3390\/ijms23115954","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4179_CR6","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s10571-023-01373-1","volume":"43","author":"W Zhao","year":"2023","unstructured":"Zhao W et al (2023) Regulated cell death of retinal ganglion cells in glaucoma: molecular insights and therapeutic potentials. Cell Mol Neurobiol 43(7):3161\u20133178. https:\/\/doi.org\/10.1007\/s10571-023-01373-1","journal-title":"Cell Mol Neurobiol"},{"issue":"9","key":"4179_CR7","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells10092394","volume":"10","author":"N Marchesi","year":"2021","unstructured":"Marchesi N, Fahmideh F, Boschi F, Pascale A, Barbieri A (2021) Ocular neurodegenerative diseases: interconnection between retina and cortical areas. Cells 10(9):2394. https:\/\/doi.org\/10.3390\/cells10092394","journal-title":"Cells"},{"issue":"1","key":"4179_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.18240\/ijo.2025.01.20","volume":"18","author":"N Cui","year":"2025","unstructured":"Cui N, He Y (2025) Glaucomatous retinal ganglion cells: death and protection. Int J Ophthalmol 18(1):160\u2013167. https:\/\/doi.org\/10.18240\/ijo.2025.01.20","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"4179_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/life12050638","volume":"12","author":"I Boccuni","year":"2022","unstructured":"Boccuni I, Fairless R (2022) Retinal glutamate neurotransmission: from physiology to pathophysiological mechanisms of retinal ganglion cell degeneration. Life 12(5):638. https:\/\/doi.org\/10.3390\/life12050638","journal-title":"Life"},{"issue":"6","key":"4179_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2174\/1566524022666220508182051","volume":"23","author":"SC Dur\u00e1n-Cristiano","year":"2023","unstructured":"Dur\u00e1n-Cristiano SC (2023) Glaucoma: biological mechanism and its clinical translation. Curr Mol Med 23(6):479\u2013491. https:\/\/doi.org\/10.2174\/1566524022666220508182051","journal-title":"Curr Mol Med"},{"key":"4179_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-71519-9_172-1","volume-title":"Handbook of neurotoxicity","author":"TE Salt","year":"2022","unstructured":"Salt TE (2022) \u2018Glutamate and neurodegeneration in the retina.\u2019 Handbook of neurotoxicity. Springer International Publishing, Cham, pp 1\u201314. https:\/\/doi.org\/10.1007\/978-3-030-71519-9_172-1"},{"issue":"2","key":"4179_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/ijms25020906","volume":"25","author":"T Tsai","year":"2024","unstructured":"Tsai T et al (2024) Glaucoma animal models beyond chronic IOP increase. Int J Mol Sci 25(2):906. https:\/\/doi.org\/10.3390\/ijms25020906","journal-title":"Int J Mol Sci"},{"issue":"15","key":"4179_CR13","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.3390\/ijms22157994","volume":"22","author":"S Vernazza","year":"2021","unstructured":"Vernazza S, Oddone F, Tirendi S, Bassi AM (2021) Risk factors for retinal ganglion cell distress in glaucoma and neuroprotective potential intervention. Int J Mol Sci 22(15):7994. https:\/\/doi.org\/10.3390\/ijms22157994","journal-title":"Int J Mol Sci"},{"key":"4179_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1527319","author":"S Sarkis","year":"2025","unstructured":"Sarkis S, Chamard C, Johansen B, Daien V, Michon F (2025) Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2025.1527319","journal-title":"Front Med (Lausanne)"},{"key":"4179_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/joph\/8476785","author":"RK Goit","year":"2025","unstructured":"Goit RK (2025) Exploring glaucoma: from pathogenesis to emerging diagnostic and management strategies. J Ophthalmol. https:\/\/doi.org\/10.1155\/joph\/8476785","journal-title":"J Ophthalmol"},{"issue":"24","key":"4179_CR16","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.3390\/cells12242797","volume":"12","author":"KM Feng","year":"2023","unstructured":"Feng KM, Tsung T-H, Chen Y-H, Lu D-W (2023) The role of retinal ganglion cell structure and function in glaucoma. Cells 12(24):2797. https:\/\/doi.org\/10.3390\/cells12242797","journal-title":"Cells"},{"issue":"7","key":"4179_CR17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/nu18071080","volume":"18","author":"J Liu","year":"2026","unstructured":"Liu J, He Z (2026) The potential of plant-derived foods to treat glaucoma: a review. Nutrients 18(7):1080. https:\/\/doi.org\/10.3390\/nu18071080","journal-title":"Nutrients"},{"issue":"4","key":"4179_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3892\/ijmm.2025.5504","volume":"55","author":"X Wang","year":"2025","unstructured":"Wang X et al (2025) The molecular mechanisms underlying retinal ganglion cell apoptosis and optic nerve regeneration in glaucoma (review). Int J Mol Med 55(4):63. https:\/\/doi.org\/10.3892\/ijmm.2025.5504","journal-title":"Int J Mol Med"},{"issue":"4","key":"4179_CR19","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.3390\/ijms25042226","volume":"25","author":"JM Boff","year":"2024","unstructured":"Boff JM, Shrestha AP, Madireddy S, Viswaprakash N, Santina LD, Vaithianathan T (2024) The interplay between neurotransmitters and calcium dynamics in retinal synapses during development, health, and disease. Int J Mol Sci 25(4):2226. https:\/\/doi.org\/10.3390\/ijms25042226","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4179_CR20","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.3390\/ijms27083607","volume":"27","author":"GL Cipriano","year":"2026","unstructured":"Cipriano GL et al (2026) Phytochemical and fungal bioactive compounds in the \u201cbrain health triad\u201d: a narrative review on neurostimulating, neurotrophic, and neuroprotective synergy. Int J Mol Sci 27(8):3607. https:\/\/doi.org\/10.3390\/ijms27083607","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4179_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2020.21899","volume":"325","author":"JD Stein","year":"2021","unstructured":"Stein JD, Khawaja AP, Weizer JS (2021) Glaucoma in adults\u2014screening, diagnosis, and management. JAMA 325(2):164. https:\/\/doi.org\/10.1001\/jama.2020.21899","journal-title":"JAMA"},{"issue":"6","key":"4179_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.mayocpiqo.2022.09.007","volume":"6","author":"IV Wagner","year":"2022","unstructured":"Wagner IV, Stewart MW, Dorairaj SK (2022) Updates on the diagnosis and management of glaucoma. Mayo Clin Proc Innov Qual Outcomes 6(6):618\u2013635. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2022.09.007","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"1","key":"4179_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/ceo.14447","volume":"53","author":"T Yang","year":"2025","unstructured":"Yang T et al (2025) Comparative analysis of medical treatments for long\u2010term control of normal tension glaucoma: a systematic review and model\u2010based network meta\u2010analysis. Clin Exp Ophthalmol 53(1):39\u201353. https:\/\/doi.org\/10.1111\/ceo.14447","journal-title":"Clin Exp Ophthalmol"},{"key":"4179_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcro.0000000000000184","author":"CL Larsen","year":"2025","unstructured":"Larsen CL et al (2025) Treatment challenges in normal tension glaucoma. J of Cataract Refractive Surg Online Case Rep. https:\/\/doi.org\/10.1097\/j.jcro.0000000000000184","journal-title":"J of Cataract Refractive Surg Online Case Rep"},{"key":"4179_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1489877","author":"X-D Hao","year":"2024","unstructured":"Hao X-D, Xu W-H, Zhang X, Xue J (2024) Targeting ferroptosis: a novel therapeutic strategy for the treatment of retinal diseases. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1489877","journal-title":"Front Pharmacol"},{"issue":"6","key":"4179_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.18240\/ijo.2025.06.21","volume":"18","author":"P Agarwal","year":"2025","unstructured":"Agarwal P, Iezhitsa I (2025) Mapping key trends, relationships, and molecular pathways for neuroprotection in glaucoma: a bibliometric approach. Int J Ophthalmol 18(6):1131\u20131145. https:\/\/doi.org\/10.18240\/ijo.2025.06.21","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"4179_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/ph17101261","volume":"17","author":"L-H Wang","year":"2024","unstructured":"Wang L-H, Huang C-H, Lin I-C (2024) Advances in neuroprotection in glaucoma: pharmacological strategies and emerging technologies. Pharmaceuticals (Basel) 17(10):1261. https:\/\/doi.org\/10.3390\/ph17101261","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"4179_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","volume":"10","author":"ML Rethlefsen","year":"2021","unstructured":"Rethlefsen ML et al (2021) PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev 10(1):39. https:\/\/doi.org\/10.1186\/s13643-020-01542-z","journal-title":"Syst Rev"},{"key":"4179_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2020","unstructured":"Page MJ et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"1","key":"4179_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-psych-010418-102803","volume":"70","author":"AP Siddaway","year":"2019","unstructured":"Siddaway AP, Wood AM, Hedges LV (2019) How to do a systematic review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses. Annu Rev Psychol 70(1):747\u2013770. https:\/\/doi.org\/10.1146\/annurev-psych-010418-102803","journal-title":"Annu Rev Psychol"},{"issue":"2","key":"4179_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1096\/fj.07-9492LSF","volume":"22","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Pitsouni EI, Malietzis GA, Pappas G (2008) Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 22(2):338\u2013342. https:\/\/doi.org\/10.1096\/fj.07-9492LSF","journal-title":"FASEB J"},{"key":"4179_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2023.1147769","author":"S Majumdar","year":"2023","unstructured":"Majumdar S (2023) Role of glutamate in the development of visual pathways. Front Ophthalmol. https:\/\/doi.org\/10.3389\/fopht.2023.1147769","journal-title":"Front Ophthalmol"},{"issue":"9","key":"4179_CR33","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.3390\/antiox11091790","volume":"11","author":"M Nebbioso","year":"2022","unstructured":"Nebbioso M et al (2022) Oxidative stress implication in retinal diseases\u2014a review. Antioxidants 11(9):1790. https:\/\/doi.org\/10.3390\/antiox11091790","journal-title":"Antioxidants"},{"issue":"12","key":"4179_CR34","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/antiox10121948","volume":"10","author":"EY-C Kang","year":"1948","unstructured":"Kang EY-C et al (1948) Role of oxidative stress in ocular diseases associated with retinal ganglion cells degeneration. Antioxidants 10(12):1948. https:\/\/doi.org\/10.3390\/antiox10121948","journal-title":"Antioxidants"},{"key":"4179_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2023.1132011","author":"M Ishikawa","year":"2023","unstructured":"Ishikawa M et al (2023) Glaucoma and microglia-induced neuroinflammation. Front Ophthalmol. https:\/\/doi.org\/10.3389\/fopht.2023.1132011","journal-title":"Front Ophthalmol"},{"key":"4179_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.699623","author":"AH Jassim","year":"2021","unstructured":"Jassim AH, Inman DM, Mitchell CH (2021) Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.699623","journal-title":"Front Pharmacol"},{"key":"4179_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.612422","author":"T Rolle","year":"2021","unstructured":"Rolle T, Ponzetto A, Malinverni L (2021) The role of neuroinflammation in glaucoma: an update on molecular mechanisms and new therapeutic options. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.612422","journal-title":"Front Neurol"},{"issue":"7","key":"4179_CR38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/08164622.2025.2463502","volume":"108","author":"X Yang","year":"2025","unstructured":"Yang X et al (2025) Metabolic dysregulation in glaucoma. Clin Exp Optom 108(7):771\u2013777. https:\/\/doi.org\/10.1080\/08164622.2025.2463502","journal-title":"Clin Exp Optom"},{"issue":"1","key":"4179_CR39","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1038\/s41598-024-54075-z","volume":"14","author":"L Feng","year":"2024","unstructured":"Feng L et al (2024) Ripa-56 protects retinal ganglion cells in glutamate-induced retinal excitotoxic model of glaucoma. Sci Rep 14(1):3834. https:\/\/doi.org\/10.1038\/s41598-024-54075-z","journal-title":"Sci Rep"},{"issue":"1","key":"4179_CR40","doi-asserted-by":"publisher","first-page":"24654","DOI":"10.1038\/s41598-024-75562-3","volume":"14","author":"X Hu","year":"2024","unstructured":"Hu X et al (2024) The broad-spectrum deubiquitinating enzyme inhibitor PR-619 protects retinal ganglion cell and augments parkin-mediated mitophagy in experimental glaucoma. Sci Rep 14(1):24654. https:\/\/doi.org\/10.1038\/s41598-024-75562-3","journal-title":"Sci Rep"},{"issue":"10","key":"4179_CR41","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.4103\/1673-5374.391193","volume":"19","author":"L Feng","year":"2024","unstructured":"Feng L et al (2024) P38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced retinal excitotoxicity glaucoma model. Neural Regen Res 19(10):2299\u20132309. https:\/\/doi.org\/10.4103\/1673-5374.391193","journal-title":"Neural Regen Res"},{"issue":"9","key":"4179_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/cells13090775","volume":"13","author":"KN Fomo","year":"2024","unstructured":"Fomo KN, Perumal N, Manicam C, Pfeiffer N, Grus FH (2024) Neuroretinal cell culture model as a tool for the development of new therapeutic approaches for oxidative stress-induced ocular diseases, with a focus on glaucoma. Cells 13(9):775. https:\/\/doi.org\/10.3390\/cells13090775","journal-title":"Cells"},{"issue":"12","key":"4179_CR43","doi-asserted-by":"publisher","first-page":"9147","DOI":"10.1097\/JS9.0000000000003213","volume":"111","author":"C Wang","year":"2025","unstructured":"Wang C et al (2025) Inhibition of Mettl3-mediated m6A RNA modification of HMGCS1 protects retinal ganglion cells from glutamate excitotoxicity-induced ferroptosis in a rat model of glaucoma. Int J Surg 111(12):9147\u20139165. https:\/\/doi.org\/10.1097\/JS9.0000000000003213","journal-title":"Int J Surg"},{"issue":"21","key":"4179_CR44","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.3390\/ijms232112753","volume":"23","author":"J Youale","year":"2022","unstructured":"Youale J et al (2022) Neuroprotective effects of transferrin in experimental glaucoma models. Int J Mol Sci 23(21):12753. https:\/\/doi.org\/10.3390\/ijms232112753","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4179_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12974-022-02626-4","volume":"19","author":"M Liu","year":"2022","unstructured":"Liu M, Li H, Yang R, Ji D, Xia X (2022) GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1\/RIP3\/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma. J Neuroinflammation 19(1):262. https:\/\/doi.org\/10.1186\/s12974-022-02626-4","journal-title":"J Neuroinflammation"},{"issue":"5","key":"4179_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.66.5.26","volume":"66","author":"H Ye","year":"2025","unstructured":"Ye H et al (2025) Ferroptosis contributes to retinal ganglion cell loss in GLAST knockout mouse model of normal tension glaucoma. Invest Ophthalmol Vis Sci 66(5):26. https:\/\/doi.org\/10.1167\/iovs.66.5.26","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"4179_CR47","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.3390\/ijms24087318","volume":"24","author":"GA Franco","year":"2023","unstructured":"Franco GA, Interdonato L, Cordaro M, Cuzzocrea S, Di Paola R (2023) Bioactive compounds of the Mediterranean diet as nutritional support to fight neurodegenerative disease. Int J Mol Sci 24(8):7318. https:\/\/doi.org\/10.3390\/ijms24087318","journal-title":"Int J Mol Sci"},{"issue":"24","key":"4179_CR48","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.3390\/nu16244368","volume":"16","author":"B Pekdemir","year":"2024","unstructured":"Pekdemir B et al (2024) Mechanisms and potential benefits of neuroprotective agents in neurological health. Nutrients 16(24):4368. https:\/\/doi.org\/10.3390\/nu16244368","journal-title":"Nutrients"},{"issue":"7","key":"4179_CR49","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/nu14071421","volume":"14","author":"M M\u0142ynarczyk","year":"2022","unstructured":"M\u0142ynarczyk M et al (2022) Diet, oxidative stress, and blood serum nutrients in various types of glaucoma: a systematic review. Nutrients 14(7):1421. https:\/\/doi.org\/10.3390\/nu14071421","journal-title":"Nutrients"},{"key":"4179_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1442548","author":"D Mat\u00edas-P\u00e9rez","year":"2024","unstructured":"Mat\u00edas-P\u00e9rez D, Varapizuela-S\u00e1nchez CF, P\u00e9rez-Campos EL, Gonz\u00e1lez-Gonz\u00e1lez S, S\u00e1nchez-Medina MA, Garc\u00eda-Montalvo IA (2024) Dietary sources of antioxidants and oxidative stress in age-related macular degeneration. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1442548","journal-title":"Front Pharmacol"},{"key":"4179_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/B978-0-12-821562-3.00004-6","volume-title":"Mitochondrial physiology and vegetal molecules","author":"N Jayapala","year":"2021","unstructured":"Jayapala N, Perumal MK, Rajasekar J, Baskaran V (2021) \u2018Plant molecules to treat eye mitochondria.\u2019 Mitochondrial physiology and vegetal molecules. Elsevier, pp 339\u2013356. https:\/\/doi.org\/10.1016\/B978-0-12-821562-3.00004-6"},{"key":"4179_CR52","doi-asserted-by":"publisher","unstructured":"J. Y. Magdaleno Roman and C. Chapa Gonz\u00e1lez (2024) \u2018Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection\u2019. John Wiley and Sons Inc https:\/\/doi.org\/10.1002\/nep3.46.","DOI":"10.1002\/nep3.46"},{"issue":"1","key":"4179_CR53","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.jpha.2025.101355","volume":"16","author":"M Qin","year":"2026","unstructured":"Qin M et al (2026) Ferroptosis and retinal ganglion cell death in glaucoma: mechanisms and therapeutic approaches. J Pharm Anal 16(1):101355. https:\/\/doi.org\/10.1016\/j.jpha.2025.101355","journal-title":"J Pharm Anal"},{"key":"4179_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440309","author":"Y Yang","year":"2024","unstructured":"Yang Y, Lin Y, Han Z, Wang B, Zheng W, Wei L (2024) Ferroptosis: a novel mechanism of cell death in ophthalmic conditions. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1440309","journal-title":"Front Immunol"},{"issue":"4","key":"4179_CR55","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4103\/1673-5374.344952","volume":"18","author":"D Basavarajappa","year":"2023","unstructured":"Basavarajappa D et al (2023) Siponimod exerts neuroprotective effects on the retina and higher visual pathway through neuronal S1PR1 in experimental glaucoma. Neural Regen Res 18(4):840\u2013848. https:\/\/doi.org\/10.4103\/1673-5374.344952","journal-title":"Neural Regen Res"},{"issue":"1","key":"4179_CR56","doi-asserted-by":"publisher","first-page":"23822","DOI":"10.1038\/s41598-025-06832-x","volume":"15","author":"H Hu","year":"2025","unstructured":"Hu H et al (2025) Neuroprotective and intraocular pressure lowering effects of dual-functional memantine nitrate MN-08 on the experimental models of glaucoma. Sci Rep 15(1):23822. https:\/\/doi.org\/10.1038\/s41598-025-06832-x","journal-title":"Sci Rep"},{"key":"4179_CR57","doi-asserted-by":"publisher","first-page":"107892","DOI":"10.1016\/j.exer.2019.107892","volume":"190","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang R, Chen J, Wu J (2020) Neuroprotective effects of DAAO are mediated via the ERK1\/2 signaling pathway in a glaucomatous animal model. Exp Eye Res 190:107892. https:\/\/doi.org\/10.1016\/j.exer.2019.107892","journal-title":"Exp Eye Res"},{"issue":"8","key":"4179_CR58","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/gtc.12971","volume":"27","author":"MM Brahma","year":"2022","unstructured":"Brahma MM, Takahashi K, Namekata K, Harada T, Goshima Y, Ohshima T (2022) Genetic inhibition of collapsin response mediator protein\u20102 phosphorylation ameliorates retinal ganglion cell death in normal\u2010tension glaucoma models. Genes Cells 27(8):526\u2013536. https:\/\/doi.org\/10.1111\/gtc.12971","journal-title":"Genes Cells"},{"issue":"1","key":"4179_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12017-024-08778-1","volume":"26","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Drug treatment attenuates retinal ganglion cell death by inhibiting collapsin response mediator protein 2 phosphorylation in mouse models of normal tension glaucoma. Neuromolecular Med 26(1):13. https:\/\/doi.org\/10.1007\/s12017-024-08778-1","journal-title":"Neuromolecular Med"},{"key":"4179_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22578","author":"HA Fachim","year":"2020","unstructured":"Fachim HA et al (2020) Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.22578","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"4179_CR61","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3923\/ijp.2022.279.291","volume":"18","author":"Y Lu","year":"2022","unstructured":"Lu Y, Chen Z, He J, Li L, Chen R, Chen J (2022) Anti-glaucoma effects of timolol and bimatoprost in novel ocular hypertension model in rats. Int J Pharmacol 18(2):279\u2013291. https:\/\/doi.org\/10.3923\/ijp.2022.279.291","journal-title":"Int J Pharmacol"},{"key":"4179_CR62","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.bbrep.2020.100777","volume":"23","author":"T Tanaka-Gonome","year":"2020","unstructured":"Tanaka-Gonome T et al (2020) The protective effect of astaxanthin on the ganglion cell complex in glutamate\/aspartate transporter deficient mice, a model of normal tension glaucoma, analyzed by spectral domain-optical coherence tomography. Biochem Biophys Rep 23:100777. https:\/\/doi.org\/10.1016\/j.bbrep.2020.100777","journal-title":"Biochem Biophys Rep"},{"key":"4179_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9539681","volume":"2020","author":"K Kikuchi","year":"2020","unstructured":"Kikuchi K et al (2020) Cytoprotective effect of astaxanthin in a model of normal intraocular pressure glaucoma. J Ophthalmol 2020:1\u20136. https:\/\/doi.org\/10.1155\/2020\/9539681","journal-title":"J Ophthalmol"},{"issue":"14","key":"4179_CR64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1167\/iovs.66.14.44","volume":"66","author":"J Su","year":"2025","unstructured":"Su J, Wang J, Gao Z, Ding L, Xia X (2025) Scutellarin protects retinal ganglion cells in glaucoma by targeting the Hsp90aa1-MAPK pathway to inhibit apoptosis. Invest Ophthalmol Vis Sci 66(14):44. https:\/\/doi.org\/10.1167\/iovs.66.14.44","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4179_CR65","doi-asserted-by":"publisher","first-page":"10187","DOI":"10.1080\/21655979.2021.2001217","volume":"12","author":"N Zhao","year":"2021","unstructured":"Zhao N, Shi J, Xu H, Luo Q, Li Q, Liu M (2021) Baicalin suppresses glaucoma pathogenesis by regulating the PI3K\/AKT signaling in vitro and in vivo. Bioengineered 12(2):10187\u201310198. https:\/\/doi.org\/10.1080\/21655979.2021.2001217","journal-title":"Bioengineered"},{"issue":"2","key":"4179_CR66","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5530\/ijper.20250444","volume":"59","author":"Y Fang","year":"2025","unstructured":"Fang Y, Meng L, Zhang R (2025) Cardamonin lowers intraocular pressure and inhibits glaucoma development in steroid induced rats by activation of Nrf 2 Ho 1 pathway. Indian J Pharm Educ Res 59(2):695\u2013703. https:\/\/doi.org\/10.5530\/ijper.20250444","journal-title":"Indian J Pharm Educ Res"},{"issue":"1","key":"4179_CR67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3923\/ijp.2023.131.138","volume":"19","author":"S Li","year":"2023","unstructured":"Li S, Ni N, Wu X, Lan T, Yu Y (2023) Protective effect of fangchinoline against glaucoma and neuroinflammation in unilateral ocular hypertension in mice. Int J Pharmacol 19(1):131\u2013138. https:\/\/doi.org\/10.3923\/ijp.2023.131.138","journal-title":"Int J Pharmacol"},{"key":"4179_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/26895293.2023.2200578","author":"IJ Okoro","year":"2023","unstructured":"Okoro IJ et al (2023) Ocular hypotensive effect of fermented Pentaclethra macrophylla seeds in experimentally-induced glaucoma. All Life. https:\/\/doi.org\/10.1080\/26895293.2023.2200578","journal-title":"All Life"},{"issue":"12","key":"4179_CR69","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.4103\/1673-5374.284998","volume":"15","author":"X-S Mi","year":"2020","unstructured":"Mi X-S, Feng Q, Lo ACY, Chang RC-C, Chung SK, So K-F (2020) Lycium barbarum polysaccharides related RAGE and A\u03b2 levels in the retina of mice with acute ocular hypertension and promote maintenance of blood retinal barrier. Neural Regen Res 15(12):2344\u20132352. https:\/\/doi.org\/10.4103\/1673-5374.284998","journal-title":"Neural Regen Res"},{"key":"4179_CR70","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.aninu.2021.07.009","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang J, Wang N, Qi M, Li J, Tan B (2022) Glutamine, glutamate, and aspartate differently modulate energy homeostasis of small intestine under normal or low energy status in piglets. Anim Nutr 8:216\u2013226. https:\/\/doi.org\/10.1016\/j.aninu.2021.07.009","journal-title":"Anim Nutr"},{"issue":"13","key":"4179_CR71","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.3390\/ijms25137037","volume":"25","author":"M Hole\u010dek","year":"2024","unstructured":"Hole\u010dek M (2024) Origin and roles of alanine and glutamine in gluconeogenesis in the liver, kidneys, and small intestine under physiological and pathological conditions. Int J Mol Sci 25(13):7037. https:\/\/doi.org\/10.3390\/ijms25137037","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4179_CR72","doi-asserted-by":"publisher","first-page":"850S","DOI":"10.3945\/ajcn.2009.27462Y","volume":"90","author":"DG Burrin","year":"2009","unstructured":"Burrin DG, Stoll B (2009) Metabolic fate and function of dietary glutamate in the gut. Am J Clin Nutr 90(3):850S-856S. https:\/\/doi.org\/10.3945\/ajcn.2009.27462Y","journal-title":"Am J Clin Nutr"},{"issue":"Suppl. 5","key":"4179_CR73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000494782","volume":"73","author":"JD Fernstrom","year":"2018","unstructured":"Fernstrom JD (2018) Monosodium glutamate in the diet does not raise brain glutamate concentrations or disrupt brain functions. Ann Nutr Metab 73(Suppl. 5):43\u201352. https:\/\/doi.org\/10.1159\/000494782","journal-title":"Ann Nutr Metab"},{"key":"4179_CR74","doi-asserted-by":"publisher","first-page":"108016","DOI":"10.1016\/j.neuropharm.2020.108016","volume":"170","author":"Q li","year":"2020","unstructured":"li Q, Jin R, Zhang S, Sun X, Wu J (2020) Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model. Neuropharmacol 170:108016. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108016","journal-title":"Neuropharmacol"},{"issue":"14","key":"4179_CR75","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.3390\/ijms22147581","volume":"22","author":"OW Gramlich","year":"2021","unstructured":"Gramlich OW, Godwin CR, Wadkins D, Elwood BW, Kuehn MH (2021) Early functional impairment in experimental glaucoma is accompanied by disruption of the GABAergic system and inceptive neuroinflammation. Int J Mol Sci 22(14):7581. https:\/\/doi.org\/10.3390\/ijms22147581","journal-title":"Int J Mol Sci"},{"key":"4179_CR76","doi-asserted-by":"publisher","unstructured":"A. Lillo et al., \u2018Targeted Metabolomics Shows That the Level of Glutamine, Kynurenine, Acyl-Carnitines and Lysophosphatidylcholines Is Significantly Increased in the Aqueous Humor of Glaucoma Patients\u2019, Front. Med. (Lausanne)., vol. 9, Jul. 2022, https:\/\/doi.org\/10.3389\/fmed.2022.935084.","DOI":"10.3389\/fmed.2022.935084"},{"key":"4179_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108268","author":"J Barbosa Breda","year":"2020","unstructured":"Barbosa Breda J et al (2020) Metabolomic profiling of aqueous humor from glaucoma patients - The metabolomics in surgical ophthalmological patients (MISO) study. Exp Eye Res. https:\/\/doi.org\/10.1016\/j.exer.2020.108268","journal-title":"Exp Eye Res"},{"issue":"1","key":"4179_CR78","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1038\/s41598-024-54383-4","volume":"14","author":"M Arai-Okuda","year":"2024","unstructured":"Arai-Okuda M et al (2024) Potentially compromised systemic and local lactate metabolic balance in glaucoma, which could increase retinal glucose and glutamate concentrations. Sci Rep 14(1):3683. https:\/\/doi.org\/10.1038\/s41598-024-54383-4","journal-title":"Sci Rep"},{"issue":"1","key":"4179_CR79","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41392-025-02438-x","volume":"10","author":"H Tian","year":"2025","unstructured":"Tian H et al (2025) Single-cell RNA-seq reveals cell type-specific molecular and genetic associations with primary open-angle glaucoma. Signal Transduct Target Ther 10(1):338. https:\/\/doi.org\/10.1038\/s41392-025-02438-x","journal-title":"Signal Transduct Target Ther"},{"key":"4179_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1366453","author":"D Wang","year":"2024","unstructured":"Wang D et al (2024) Identification of immune-related biomarkers for glaucoma using gene expression profiling. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2024.1366453","journal-title":"Front Genet"},{"key":"4179_CR81","doi-asserted-by":"publisher","first-page":"145455","DOI":"10.1016\/j.ijbiomac.2025.145455","volume":"319","author":"D Wang","year":"2025","unstructured":"Wang D et al (2025) Integrated single-cell RNA and ATAC sequencing of B-cell lymphoma-3(Bcl3) and endothelin-2(Edn2) proteins as targets to prevent glaucoma progression. Int J Biol Macromol 319:145455. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145455","journal-title":"Int J Biol Macromol"},{"key":"4179_CR82","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejbt.2023.10.002","volume":"67","author":"Z Xie","year":"2024","unstructured":"Xie Z, Wang H, Liu L, Zhang H, Liu J (2024) Long non-coding RNA KCNQ1 opposite strand\/antisense transcript 1, a potential biomarker for glaucoma, accelerates glaucoma progression via microRNA-93-5p\/Homeobox box 3 axis. Electron J Biotechnol 67:23\u201333. https:\/\/doi.org\/10.1016\/j.ejbt.2023.10.002","journal-title":"Electron J Biotechnol"},{"key":"4179_CR83","doi-asserted-by":"publisher","first-page":"135441","DOI":"10.1016\/j.snb.2024.135441","volume":"406","author":"Y Lan","year":"2024","unstructured":"Lan Y et al (2024) An endoplasmic reticulum-targeted NIR fluorescent nanoprobe for early diagnosis of glaucoma in vivo. Sens Actuators B Chem 406:135441. https:\/\/doi.org\/10.1016\/j.snb.2024.135441","journal-title":"Sens Actuators B Chem"},{"issue":"18","key":"4179_CR84","doi-asserted-by":"publisher","first-page":"9109","DOI":"10.3390\/ijms26189109","volume":"26","author":"SC Dur\u00e1n-Cristiano","year":"2025","unstructured":"Dur\u00e1n-Cristiano SC et al (2025) Exploring molecular and clinical dimensions of glaucoma as a neurodegenerative disease. Int J Mol Sci 26(18):9109. https:\/\/doi.org\/10.3390\/ijms26189109","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4179_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.65.8.15","volume":"65","author":"Y Pang","year":"2024","unstructured":"Pang Y et al (2024) Contributions of brain microstructures and metabolism to visual field loss patterns in glaucoma using archetypal and information gain analyses. Invest Ophthalmol Vis Sci 65(8):15. https:\/\/doi.org\/10.1167\/iovs.65.8.15","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4179_CR86","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/brainsci12060780","volume":"12","author":"Z Yan","year":"2022","unstructured":"Yan Z, Lai M, Jia Y, Deng C, Zhuo Y (2022) CircXPO5 plays a neuroprotective function in the lateral geniculate nucleus of glaucoma by regulating GRIN2A. Brain Sci 12(6):780. https:\/\/doi.org\/10.3390\/brainsci12060780","journal-title":"Brain Sci"},{"issue":"8","key":"4179_CR87","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/ph16081172","volume":"16","author":"ML Salvetat","year":"2023","unstructured":"Salvetat ML, Pellegrini F, Spadea L, Salati C, Zeppieri M (2023) Pharmaceutical approaches to normal tension glaucoma. Pharmaceuticals 16(8):1172. https:\/\/doi.org\/10.3390\/ph16081172","journal-title":"Pharmaceuticals"},{"key":"4179_CR88","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/978-3-031-15080-7_84","volume-title":"Handbook of neurotoxicity","author":"GN Turski","year":"2022","unstructured":"Turski GN, Ikonomidou C (2022) \u2018Glutamate as a neurotoxin.\u2019 Handbook of neurotoxicity. Springer International Publishing, Cham, pp 769\u2013801. https:\/\/doi.org\/10.1007\/978-3-031-15080-7_84"},{"issue":"2","key":"4179_CR89","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.aopr.2025.03.002","volume":"5","author":"T Liu","year":"2025","unstructured":"Liu T et al (2025) The impact of intraocular pressure fluctuations on the progression of glaucoma and associated factors. Adv Ophthalmol Pract Res 5(2):142\u2013148. https:\/\/doi.org\/10.1016\/j.aopr.2025.03.002","journal-title":"Adv Ophthalmol Pract Res"},{"issue":"3","key":"4179_CR90","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11064-025-04400-3","volume":"50","author":"G Zhang","year":"2025","unstructured":"Zhang G, Huang S, Wei M, Wu Y, Wang J (2025) Excitatory amino acid transporters as therapeutic targets in the treatment of neurological disorders: their roles and therapeutic prospects. Neurochem Res 50(3):155. https:\/\/doi.org\/10.1007\/s11064-025-04400-3","journal-title":"Neurochem Res"},{"key":"4179_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14617","author":"D Zhang","year":"2024","unstructured":"Zhang D, Hua Z, Li Z (2024) The role of glutamate and glutamine metabolism and related transporters in nerve cells. CNS Neurosci Ther. https:\/\/doi.org\/10.1111\/cns.14617","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"4179_CR92","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/biom12040597","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chu J-M-T, Wong G-T-C (2022) Cerebral glutamate regulation and receptor changes in perioperative neuroinflammation and cognitive dysfunction. Biomolecules 12(4):597. https:\/\/doi.org\/10.3390\/biom12040597","journal-title":"Biomolecules"},{"issue":"9","key":"4179_CR93","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3390\/biomedicines12092000","volume":"12","author":"H-P Lee","year":"2024","unstructured":"Lee H-P, Tsung T-H, Tsai Y-C, Chen Y-H, Lu D-W (2024) Glaucoma: current and new therapeutic approaches. Biomed 12(9):2000. https:\/\/doi.org\/10.3390\/biomedicines12092000","journal-title":"Biomed"},{"key":"4179_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DDDT.S612176","volume":"20","author":"S Rho","year":"2026","unstructured":"Rho S, Williams P (2026) Prospects for neuroprotective therapies in glaucoma: drug targets and emerging clinical strategies. Drug Des Devel Ther 20:1\u201319. https:\/\/doi.org\/10.2147\/DDDT.S612176","journal-title":"Drug Des Devel Ther"},{"key":"4179_CR95","unstructured":"J. G. Serkiz, \u2018Targeting nmda receptor-mediated glutamate release to prevent retinal ganglion cell degeneration in glaucoma\u2019."},{"issue":"22","key":"4179_CR96","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.3390\/ijms21228765","volume":"21","author":"CO Reichert","year":"2020","unstructured":"Reichert CO et al (2020) Ferroptosis mechanisms involved in neurodegenerative diseases. Int J Mol Sci 21(22):8765. https:\/\/doi.org\/10.3390\/ijms21228765","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4179_CR97","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/ph18030334","volume":"18","author":"H Wang","year":"2025","unstructured":"Wang H, Xie Y (2025) Advances in ferroptosis research: a comprehensive review of mechanism exploration, drug development, and disease treatment. Pharmaceuticals (Basel) 18(3):334. https:\/\/doi.org\/10.3390\/ph18030334","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"4179_CR98","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mco2.108","volume":"2","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) The role of necroptosis in disease and treatment. MedComm (NY) 2(4):730\u2013755. https:\/\/doi.org\/10.1002\/mco2.108","journal-title":"MedComm (NY)"},{"issue":"2","key":"4179_CR99","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/nep3.46","volume":"2","author":"JY Magdaleno Roman","year":"2024","unstructured":"Magdaleno Roman JY, Chapa Gonz\u00e1lez C (2024) Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection. Neuroprotection (New York NY) 2(2):137\u2013150. https:\/\/doi.org\/10.1002\/nep3.46","journal-title":"Neuroprotection (New York NY)"},{"issue":"12","key":"4179_CR100","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1038\/s41401-025-01576-w","volume":"46","author":"W Wu","year":"2025","unstructured":"Wu W, Gong X, Qin Z, Wang Y (2025) Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014an update. Acta Pharmacol Sin 46(12):3129\u20133142. https:\/\/doi.org\/10.1038\/s41401-025-01576-w","journal-title":"Acta Pharmacol Sin"},{"key":"4179_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1354569","author":"JA Fern\u00e1ndez-Albarral","year":"2024","unstructured":"Fern\u00e1ndez-Albarral JA et al (2024) Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2024.1354569","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"4179_CR102","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10072-024-07880-3","volume":"46","author":"Y Dhurandhar","year":"2025","unstructured":"Dhurandhar Y, Tomar S, Namdeo KP, Bodakhe SH (2025) Excitatory amino acids as therapeutic agents: reversing neurodegenerative trajectory by tackling excitotoxicity. Neurol Sci 46(2):549\u2013560. https:\/\/doi.org\/10.1007\/s10072-024-07880-3","journal-title":"Neurol Sci"},{"issue":"12","key":"4179_CR103","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.3390\/ijms25126521","volume":"25","author":"N Nicosia","year":"2024","unstructured":"Nicosia N, Giovenzana M, Misztak P, Mingardi J, Musazzi L (2024) Glutamate-mediated excitotoxicity in the pathogenesis and treatment of neurodevelopmental and adult mental disorders. Int J Mol Sci 25(12):6521. https:\/\/doi.org\/10.3390\/ijms25126521","journal-title":"Int J Mol Sci"},{"key":"4179_CR104","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-981-99-7557-0_47","volume-title":"Handbook of neurodegenerative disorders","author":"SMHM Elmogheer","year":"2024","unstructured":"Elmogheer SMHM (2024) \u2018Mechanisms of neuronal apoptosis and excitotoxicity.\u2019 Handbook of neurodegenerative disorders. Springer Nature Singapore, Singapore, pp 435\u2013474. https:\/\/doi.org\/10.1007\/978-981-99-7557-0_47"},{"issue":"1","key":"4179_CR105","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1038\/s41598-021-89137-z","volume":"11","author":"SK Pulukool","year":"2021","unstructured":"Pulukool SK et al (2021) Elevated dimethylarginine, ATP, cytokines, metabolic remodeling involving tryptophan metabolism and potential microglial inflammation characterize primary open angle glaucoma. Sci Rep 11(1):9766. https:\/\/doi.org\/10.1038\/s41598-021-89137-z","journal-title":"Sci Rep"},{"issue":"17","key":"4179_CR106","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.3390\/jcm14176145","volume":"14","author":"A Martucci","year":"2025","unstructured":"Martucci A et al (2025) Next-gen neuroprotection in glaucoma: synergistic molecules for targeted therapy. J Clin Med 14(17):6145. https:\/\/doi.org\/10.3390\/jcm14176145","journal-title":"J Clin Med"},{"key":"4179_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1577200","author":"B Lin","year":"2025","unstructured":"Lin B, Li D (2025) The pivotal role of inflammatory factors in glaucoma: a systematic review. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1577200","journal-title":"Front Immunol"},{"key":"4179_CR108","doi-asserted-by":"publisher","first-page":"102636","DOI":"10.1016\/j.ebiom.2020.102636","volume":"52","author":"KJ Wert","year":"2020","unstructured":"Wert KJ et al (2020) Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration. EBioMedicine 52:102636. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102636","journal-title":"EBioMedicine"},{"key":"4179_CR109","doi-asserted-by":"publisher","unstructured":"H. Gao, S. Chen, L. A, H. Xu, J. Xie, and Z. Q. Yin (2023) \u2018Transplanted OECs Protect Visual Function by Regulating the Glutamate Metabolic Microenvironment in the Glaucoma Model\u2019. J Integr Neurosci https:\/\/doi.org\/10.31083\/j.jin2203055.","DOI":"10.31083\/j.jin2203055"},{"key":"4179_CR110","doi-asserted-by":"publisher","first-page":"116538","DOI":"10.1016\/j.biopha.2024.116538","volume":"174","author":"L-H Wu","year":"2024","unstructured":"Wu L-H et al (2024) A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant M\u00fcller glia activation and oxidative stress. Biomed Pharmacother 174:116538. https:\/\/doi.org\/10.1016\/j.biopha.2024.116538","journal-title":"Biomed Pharmacother"},{"key":"4179_CR111","doi-asserted-by":"publisher","unstructured":"M. M. Moschos (2024) \u2018Is there an implication of nutrition and lifestyle habits in glaucoma disease? a systematic review\u2019. J Ophthalmol Adv Res https:\/\/doi.org\/10.46889\/JOAR.2024.5105","DOI":"10.46889\/JOAR.2024.5105"},{"key":"4179_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1525623","author":"H Sun","year":"2025","unstructured":"Sun H, Hao Y, Liu H, Gao F (2025) The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1525623","journal-title":"Front Immunol"},{"issue":"2","key":"4179_CR113","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4103\/ijo.IJO_1158_21","volume":"70","author":"CR Vishwaraj","year":"2022","unstructured":"Vishwaraj CR, Kavitha S, Venkatesh R, Shukla AG, Chandran P, Tripathi S (2022) Neuroprotection in glaucoma. Indian J Ophthalmol 70(2):380\u2013385. https:\/\/doi.org\/10.4103\/ijo.IJO_1158_21","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"4179_CR114","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/1673-5374.344831","volume":"18","author":"W-C Shen","year":"2023","unstructured":"Shen W-C, Huang B-Q, Yang J (2023) Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies. Neural Regen Res 18(1):87. https:\/\/doi.org\/10.4103\/1673-5374.344831","journal-title":"Neural Regen Res"},{"key":"4179_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq1081","author":"Y Shinozaki","year":"2022","unstructured":"Shinozaki Y et al (2022) Astrocytic dysfunction induced by ABCA1 deficiency causes optic neuropathy. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abq1081","journal-title":"Sci Adv"},{"issue":"4","key":"4179_CR116","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41419-020-2456-6","volume":"11","author":"G Edwards","year":"2020","unstructured":"Edwards G et al (2020) Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells. Cell Death Dis 11(4):254. https:\/\/doi.org\/10.1038\/s41419-020-2456-6","journal-title":"Cell Death Dis"},{"issue":"16","key":"4179_CR117","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","volume":"184","author":"X Guo","year":"2021","unstructured":"Guo X et al (2021) Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell 184(16):4299-4314.e12. https:\/\/doi.org\/10.1016\/j.cell.2021.06.031","journal-title":"Cell"},{"issue":"5","key":"4179_CR118","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/cxo.13031","volume":"103","author":"AY Wang","year":"2020","unstructured":"Wang AY et al (2020) Potential mechanisms of retinal ganglion cell type\u2010specific vulnerability in glaucoma. Clin Exp Optom 103(5):562\u2013571. https:\/\/doi.org\/10.1111\/cxo.13031","journal-title":"Clin Exp Optom"},{"issue":"3","key":"4179_CR119","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/cells9030677","volume":"9","author":"N Yang","year":"2020","unstructured":"Yang N, Young BK, Wang P, Tian N (2020) The susceptibility of retinal ganglion cells to optic nerve injury is type specific. Cells 9(3):677. https:\/\/doi.org\/10.3390\/cells9030677","journal-title":"Cells"},{"key":"4179_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.566922","author":"J Chen","year":"2020","unstructured":"Chen J, Liu X, Zhong Y (2020) Interleukin-17A: the key cytokine in neurodegenerative diseases. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2020.566922","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"4179_CR121","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/cells10061368","volume":"10","author":"AM Boal","year":"2021","unstructured":"Boal AM, Risner ML, Cooper ML, Wareham LK, Calkins DJ (2021) Astrocyte networks as therapeutic targets in glaucomatous neurodegeneration. Cells 10(6):1368. https:\/\/doi.org\/10.3390\/cells10061368","journal-title":"Cells"},{"issue":"11","key":"4179_CR122","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3390\/jpm12111884","volume":"12","author":"C-Y Kuo","year":"2022","unstructured":"Kuo C-Y, Liu CJ-L (2022) Neuroprotection in glaucoma: basic aspects and clinical relevance. J Pers Med 12(11):1884. https:\/\/doi.org\/10.3390\/jpm12111884","journal-title":"J Pers Med"},{"issue":"2","key":"4179_CR123","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/cells10020295","volume":"10","author":"JR Tribble","year":"2021","unstructured":"Tribble JR et al (2021) Targeting diet and exercise for neuroprotection and neurorecovery in glaucoma. Cells 10(2):295. https:\/\/doi.org\/10.3390\/cells10020295","journal-title":"Cells"},{"key":"4179_CR124","doi-asserted-by":"publisher","unstructured":"M. Musa et al (2023) Nutritional factors: benefits in glaucoma and ophthalmologic pathologies. Life13(5):1120 https:\/\/doi.org\/10.3390\/life13051120.","DOI":"10.3390\/life13051120"},{"key":"4179_CR125","doi-asserted-by":"publisher","unstructured":"M. C. Medori, Z. Naureen, K. Dhuli, G. Placidi, B. Falsini, and M. Bertelli, \u2018Dietary supplements in retinal diseases, glaucoma, and other ocular conditions\u2019, Jun. 01, 2022, NLM (Medline). https:\/\/doi.org\/10.15167\/2421-4248\/jpmh2022.63.2S3.2760.","DOI":"10.15167\/2421-4248\/jpmh2022.63.2S3.2760"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04179-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:29:52Z","timestamp":1784874592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4179"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04179-4","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"310"}}